ICD-10-CM Billable Code

L74.519

Primary focal hyperhidrosis, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Primary focal hyperhidrosis is a medical condition characterized by excessive sweating localized to specific areas of the body, such as the hands, feet, underarms, or face. When the cause of this condition is not linked to other health issues, it is classified as primary focal hyperhidrosis underscored by ICD-10 code L74.519. This condition often begins in adolescence or early adulthood and can significantly impact daily life, social interactions, and emotional well-being.

Causes & Symptoms

Clinical Causes: Overactive sweat glands signaling a problem in the nervous system without an apparent underlying health condition. Genetic predisposition, as the condition often runs in families. Disruption in the sympathetic nervous system responsible for regulating sweating. Environmental or emotional factors that may trigger episodes of excessive sweating.

Key Symptoms: Excessive sweating localized to specific areas, such as the hands, feet, underarms, or face. Sweating that persists for at least six months without apparent reason. Sweat that occurs even when at rest or in cool environments. Clammy or moist skin in affected areas. Potential discomfort or embarrassment due to visible sweating. Possible skin irritation or infections resulting from constant moisture.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of primary focal hyperhidrosis typically involves a thorough medical history and physical examination. Healthcare providers may perform certain tests, such as the Minor starch-iodine test, to identify the extent and location of excessive sweating. The diagnosis is primarily clinical and based on criteria such as persistent sweating in specific areas for at least six months without an underlying illness. Additional investigations may be conducted to rule out secondary hyperhidrosis caused by other medical conditions.

Treatment Protocols: Topical treatments: Prescription antiperspirants containing aluminum chloride are often recommended as a first-line approach. Medications: Oral medications, such as anticholinergic drugs, may be prescribed for more severe cases, although they may have side effects. Botulinum toxin injections: Botox can temporarily block nerve signals responsible for sweating in targeted areas, providing relief for several months. Iontophoresis: A procedure that uses a device to pass mild electrical currents through water to reduce sweating, particularly effective for hands and feet. Surgery: In refractory cases, procedures like endoscopic thoracic sympathectomy (ETS) can be considered to interrupt nerve pathways involved in sweating. Lifestyle modifications: Wearing breathable clothing, avoiding triggers like spicy foods or caffeine, and practicing good hygiene can help manage symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L74.519 a billable ICD-10 code?
Yes, L74.519 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L74.519?
Clinical documentation must specify the nature of Primary focal hyperhidrosis, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

primary focal